We are live on
!
Find out more
Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$180B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
+22.93%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$8.74B
AUM Growth
+$2.28B
(+35%)
Cap. Flow
+$891M
Cap. Flow
% of AUM
10.19%
Top 10 Holdings %
Top 10 Hldgs %
23.52%
Holding
1,049
New
43
Increased
781
Reduced
144
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$49.6M |
| 2 |
iShares MBS ETF
MBB
|
+$47.2M |
| 3 |
Microsoft
MSFT
|
+$43.7M |
| 4 |
Home Depot
HD
|
+$32.8M |
| 5 |
Apple
AAPL
|
+$27.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Planet Fitness
PLNT
|
+$22.6M |
| 2 |
McDonald's
MCD
|
+$14.3M |
| 3 |
Ulta Beauty
ULTA
|
+$12.5M |
| 4 |
AGN
Allergan plc
AGN
|
+$11.8M |
| 5 |
RTX Corp
RTX
|
+$8.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.36% |
| 2 | Healthcare | 13% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 10.93% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYRS
876
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $221K | ﹤0.01% |
+2,076
| New | +$186K |
|
877
CRISPR Therapeutics
CRSP
$5.17B
| $220K | ﹤0.01% |
2,999
+389
| +15% | +$22.7K |
|
878
Saic
SAIC
$5.3B
| $219K | ﹤0.01% |
2,822
-732
| -21% | -$60K |
|
|
SAFE
879
DELISTED
Safehold Inc.
SAFE
| $218K | ﹤0.01% |
3,786
+530
| +16% | +$29K |
|
|
TECX
880
Tectonic Therapeutic
TECX
$639M
| $217K | ﹤0.01% |
+1,035
| New | +$213K |
|
881
Q32 Bio
QTTB
$466M
| $216K | ﹤0.01% |
791
+102
| +15% | +$27.2K |
|
882
Bath & Body Works
BBWI
$3.89B
| $214K | ﹤0.01% |
17,669
-291,561
| -94% | -$3.25M |
|
883
Twist Bioscience
TWST
$7.83B
| $214K | ﹤0.01% |
+4,731
| New | +$170K |
|
|
GAP
884
The Gap Inc
GAP
$7.74B
| $214K | ﹤0.01% |
16,987
-23,460
| -58% | -$211K |
|
885
AngioDynamics
ANGO
$651M
| $213K | ﹤0.01% |
20,978
+6,295
| +43% | +$64.9K |
|
|
NXRT
886
NexPoint Residential Trust
NXRT
$641M
| $213K | ﹤0.01% |
6,015
+122
| +2% | +$3.78K |
|
887
Rocket Pharmaceuticals
RCKT
$397M
| $210K | ﹤0.01% |
10,020
-1,542
| -13% | -$27.8K |
|
888
Editas Medicine
EDIT
$432M
| $208K | ﹤0.01% |
7,040
-100
| -1% | -$2.61K |
|
889
Ultragenyx Pharmaceutical
RARE
$2.64B
| $208K | ﹤0.01% |
2,660
-2,014
| -43% | -$133K |
|
890
Intellia Therapeutics
NTLA
$1.68B
| $206K | ﹤0.01% |
9,817
-2,085
| -18% | -$35.4K |
|
891
Tanger
SKT
$4.44B
| $203K | ﹤0.01% |
28,465
+4,039
| +17% | +$26.7K |
|
|
ADVM
892
DELISTED
Adverum Biotechnologies
ADVM
| $202K | ﹤0.01% |
967
-854
| -47% | -$151K |
|
|
TNAV
893
DELISTED
Telenav Inc.
TNAV
| $201K | ﹤0.01% |
36,528
+701
| +2% | +$3.47K |
|
|
BLUE
894
DELISTED
bluebird bio
BLUE
| $200K | ﹤0.01% |
253
+67
| +36% | +$50.5K |
|
|
BEST
895
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $200K | ﹤0.01% |
2,331
+871
| +60% | +$89.5K |
|
|
AEGN
896
DELISTED
Aegion Corp
AEGN
| $198K | ﹤0.01% |
12,455
+3,314
| +36% | +$49.3K |
|
897
Xencor
XNCR
$1.6B
| $197K | ﹤0.01% |
6,094
+1,366
| +29% | +$41.9K |
|
898
Codexis
CDXS
$161M
| $196K | ﹤0.01% |
17,179
+5,246
| +44% | +$59.3K |
|
899
Infosys
INFY
$50.9B
| $195K | ﹤0.01% |
20,210
-9,163
| -31% | -$81.8K |
|
900
Xerox
XRX
$427M
| $194K | ﹤0.01% |
12,674
-28,091
| -69% | -$485K |
|
Similar funds
VGA
Mitsubishi UFJ Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Mitsubishi UFJ Asset Management held 1,049 positions worth $8.74B, up 35% from $6.47B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Mitsubishi UFJ Asset Management deployed $891M of net new capital in Q2 2020, opening 43 new positions and adding to 781 existing holdings. Its largest new stake was iShares Global REIT ETF: 1,055,900 shares worth $22M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Planet Fitness, an estimated $22.6M trimmed.
- Mitsubishi UFJ Asset Management's largest Q2 2020 buy was iShares Global REIT ETF: 1,055,900 shares worth $22M.
- Mitsubishi UFJ Asset Management added most to iShares JPMorgan USD Emerging Markets Bond ETF in Q2 2020, an estimated $49.6M increase.
- Mitsubishi UFJ Asset Management's biggest Q2 2020 reduction was Planet Fitness, cutting an estimated $22.6M.
- Mitsubishi UFJ Asset Management fully exited Allergan plc in Q2 2020, selling an estimated $11.8M.
- Mitsubishi UFJ Asset Management's ten largest holdings make up 24% of its $8.74B portfolio in Q2 2020.
- Mitsubishi UFJ Asset Management opened 43 new positions and closed 43 in Q2 2020.
- Mitsubishi UFJ Asset Management's portfolio value rose 35% quarter-over-quarter to $8.74B.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2020, filed 6 Aug 2020.